Search - Prime Therapeutics
Navigate to
-
Experience a different kind of PBM We’re your trusted, transparent partner that’s reimagining pharmacy solutions to deliver value back to those we serve and transforming our industry for the...
-
Upgrade provides streamlined patient support and enhanced digital engagement for data-driven, holistic care
PA Sub-Categories: Specialty drugs Products Prime Article: Press Releases -
-
Prime Careers Spotlight: November 2024 Check out our latest job openings. Together, we can help make health care better by helping clients and members navigate pharmacy benefits. Investment...
-
Notice of Privacy Practices To allow a family member or agent to contact Prime on your behalf, please print, complete and return the release form below: Authorization for Release of Information |...
-
Annual conference features presentations, panels, discussions and networking
Prime Article: Stories -
Breadcrumb Home Newsroom Custom Content Publications High-Cost Therapy Profile: September 2024 PUBLIcATIonS High-Cost Therapy Profile: September 2024 Detailed information about Intravenous (IV)...
-
PUBLICATIONS FDA Decisions Expected: April 2025 Your monthly synopsis of new drugs expected to hit the market March 14, 2025 Drug pipeline for April 2025 At Prime Therapeutics (Prime), we have...
-
Cover image for Prime Therapeutics prioritizes patient-centered care, stays ahead of oncology trends Prime simplifies the cancer care pathway through innovative solutions that help manage complex...
PA Sub-Categories: Specialty drugs Products Prime Article: Stories -
Breadcrumb Home Newsroom Custom Content Prime Careers Spotlight Prime Careers Spotlight: July 2025 Prime Careers Spotlight: July 2025 Check out our latest job openings. Together, we can help make...
-
Dinesh Kandanchatha joined the organization July 1.
Prime Article: Press Releases -
publications Drug Approvals: November 2024 Critical updates in an ever-changing environment This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a...
-
Managed Markets Insight & Technology (MMIT)
PA Sub-Categories: Specialty drugs Products Prime Article: In the News -
publications BiTEs and roadblocks June 25, 2025 Author: Simone Ndujiuba, PharmD, BCOP US Food and Drug Administration (FDA) has approved fourteen bispecific antibody drugs to treat a variety of...
-
Start a medication therapy management internship Get hands-on pharmacy experience and develop leadership, strategic-planning and patient care skills with our medication therapy management and...
-
Expert Clinical Network Insights Metastatic Synovial Sarcoma October 21, 2024 Medication insights: afamitresgene autoleucel (Tecelra) The U.S. Food and Drug Administration (FDA) approved...
-
Second annual report gives a transparent overview of Prime’s organizational makeup, highlights milestones along its journey
PA Sub-Categories: Corporate responsibility Prime Article: Stories -
oncology insights Decoding Cancer: How Genetic and Genomic Testing Advance Treatment December 13, 2024 Scientists have made remarkable progress in understanding the thousands of genes inside our...
-
Latest edition of Prime Therapeutics Report spotlights seismic shift in how best to diagnose and manage transthyretin amyloid cardiomyopathy (ATTR-CM) and what it means for patients, providers and...
PA Sub-Categories: Specialty drugs Prime Article: Stories -
Perspectives Oncology Insights: First-in-class bladder cancer therapy and the Bacillus Calmette-Guérin (BCG) shortage Approximately 83,000 new bladder cancer cases are diagnosed in the U.S. in each...
-
publications Radiopharmaceutical discovery and use is gaining momentum March 14, 2025 Author: Abby Kim, PharmD, BCOP Introducing Abby Kim, PharmD, BCOP Abby Kim, a Board-Certified Oncology...
-
Diversity, equity and inclusion Our commitment to diversity, equity and inclusion (DEI) is rooted in our purpose and dedication to serving others. Breadcrumb Home Who we are Culture Diversity,...
-
Oncology Insights: Transformative treatment for small cell lung cancer After decades of research, a new treatment is emerging for this aggressive form of lung cancer. By: Simone Ndujiuba, PharmD,...
-
Commercial formularies Breadcrumb Home Other Navigation Pharmacy + Providers Commercial Formularies PrimeChoice Accord Formulary PrimeChoice Accord Formulary Updates NetResults A-Series...
-
Effective: January 2021 Terms of use IF YOU ARE EXPERIENCING A MEDICAL EMERGENCY, DIAL 911 AND/OR SEEK IMMEDIATE ATTENTION FROM A HEALTH CARE PROVIDER. THIS WEBSITE DOES NOT PROVIDE MEDICAL...
-
Breadcrumb Prime Therapeutics Newsroom Custom Content Publications Drug Approvals: October 2024 PUBLICATIONS Drug Approvals: October 2024 This monthly update of United States (U.S.) Food and Drug...
-
Identifying the associated medical cost savings with improving medication adherence study earns organization’s platinum award.
PA Sub-Categories: GLP-1 Specialty drugs Prime Article: Press Releases -
publications Drug Approvals: March 2025 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches March 26, 2025 Specialty New drugs March...
-
Pharmacy Times
PA Sub-Categories: Specialty drugs Prime Article: In the News -
Fall 2024 edition provides insights into groundbreaking specialty solutions for managed care
PA Sub-Categories: Specialty drugs Prime Article: Stories -
publications Drug Approvals: April 2025 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches April 29, 2025 Specialty New drugs March...
-
-
Check inquiry Breadcrumb Home Other Navigation Pharmacy + Providers Check inquiry This form is specifically used to request a check reissue. For remittance requests, please use the following link:...
-
Cover image for The state of value-based contracting 2.0 An update on Medicaid payment models and opportunities Prime Therapeutics Value-based contracts (VBCs) are performance-based reimbursement...
Prime Article: Research & Publications PA Research & Publications: White Papers -
Drug Approvals Monthly Update: October 2024 This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a review of newly approved specialty drugs, new...
Prime Article: Research & Publications PA Research & Publications: Drug Approvals -
Disclaimer THIS WEBSITE IS AN OPTIONAL RESOURCE FOR HEALTH CARE PROVIDERS ONLY. IF YOU ARE NOT A HEALTH CARE PROVIDER OR AUTHORIZED PROFESSIONAL USER, YOU ARE NOT TO USE THIS SITE AT ALL AND ARE...
-
Prime Perspective Breadcrumb Home Other Navigation Pharmacy + Providers Prime Perspective Pharmacy newsletter from Prime Therapeutics that provides information and updates about Prime services....
-
publications Fall 2024 Prime Therapeutics Report October 21, 2024 Debuting a new name and design, the 41st edition of our managed care report still offers the same in-depth industry articles on...
-
cover image for Drug Approvals: December 2024 Critical updates in an ever-changing environment Prime Therapeutics /drug-approvals-december-2024 About Prime Therapeutics Prime Therapeutics logo...
Prime Article: Research & Publications PA Research & Publications: Drug Approvals -
Cover image for Drug approvals Critical updates in an ever-changing environment Prime Therapeutics /drug-approvals-december-2024 About Prime Therapeutics Prime Therapeutics logo Prime Therapeutics...
Prime Article: Research & Publications PA Research & Publications: Drug Approvals